Global Neuromodulation and Neurostimulation Pain Management Devices Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our latest research, the global Neuromodulation and Neurostimulation Pain Management Devices market size will reach USD 3554 million in 2031, growing at a CAGR of 6.3% over the analysis period.
Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Neuromodulation and Neurostimulation Pain Management Devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, Facial & Migraine Pain, Musculoskeletal Pain, and others.
Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.
This report is a detailed and comprehensive analysis for global Neuromodulation and Neurostimulation Pain Management Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neuromodulation and Neurostimulation Pain Management Devices market size and forecasts, in consumption value ($ Million), 2020-2031
Global Neuromodulation and Neurostimulation Pain Management Devices market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Neuromodulation and Neurostimulation Pain Management Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Neuromodulation and Neurostimulation Pain Management Devices market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuromodulation and Neurostimulation Pain Management Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neuromodulation and Neurostimulation Pain Management Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic Plc, Boston Scientific Corporation, Pfizer Inc. (Hospira Inc.), Johnson & Johnson (Codman And Shurtleff, Inc.), Stryker Corporation, Kimberly-Clark Corporation (Baylis Medical), Colfax Corporation (Djo Global Llc), Abbott Laboratories, B Braun Melsungen Ag, Baxter International Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Neuromodulation and Neurostimulation Pain Management Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Spinal Cord Stimulators
Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Market segment by Application
Neuropathic Pain
Cancer Pain
Facial & Migraine Pain
Musculoskeletal Pain
Others
Market segment by players, this report covers
Medtronic Plc
Boston Scientific Corporation
Pfizer Inc. (Hospira Inc.)
Johnson & Johnson (Codman And Shurtleff, Inc.)
Stryker Corporation
Kimberly-Clark Corporation (Baylis Medical)
Colfax Corporation (Djo Global Llc)
Abbott Laboratories
B Braun Melsungen Ag
Baxter International Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neuromodulation and Neurostimulation Pain Management Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neuromodulation and Neurostimulation Pain Management Devices, with revenue, gross margin, and global market share of Neuromodulation and Neurostimulation Pain Management Devices from 2020 to 2025.
Chapter 3, the Neuromodulation and Neurostimulation Pain Management Devices competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Neuromodulation and Neurostimulation Pain Management Devices market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neuromodulation and Neurostimulation Pain Management Devices.
Chapter 13, to describe Neuromodulation and Neurostimulation Pain Management Devices research findings and conclusion.
Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Neuromodulation and Neurostimulation Pain Management Devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, Facial & Migraine Pain, Musculoskeletal Pain, and others.
Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.
This report is a detailed and comprehensive analysis for global Neuromodulation and Neurostimulation Pain Management Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neuromodulation and Neurostimulation Pain Management Devices market size and forecasts, in consumption value ($ Million), 2020-2031
Global Neuromodulation and Neurostimulation Pain Management Devices market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Neuromodulation and Neurostimulation Pain Management Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Neuromodulation and Neurostimulation Pain Management Devices market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuromodulation and Neurostimulation Pain Management Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neuromodulation and Neurostimulation Pain Management Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic Plc, Boston Scientific Corporation, Pfizer Inc. (Hospira Inc.), Johnson & Johnson (Codman And Shurtleff, Inc.), Stryker Corporation, Kimberly-Clark Corporation (Baylis Medical), Colfax Corporation (Djo Global Llc), Abbott Laboratories, B Braun Melsungen Ag, Baxter International Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Neuromodulation and Neurostimulation Pain Management Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Spinal Cord Stimulators
Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Market segment by Application
Neuropathic Pain
Cancer Pain
Facial & Migraine Pain
Musculoskeletal Pain
Others
Market segment by players, this report covers
Medtronic Plc
Boston Scientific Corporation
Pfizer Inc. (Hospira Inc.)
Johnson & Johnson (Codman And Shurtleff, Inc.)
Stryker Corporation
Kimberly-Clark Corporation (Baylis Medical)
Colfax Corporation (Djo Global Llc)
Abbott Laboratories
B Braun Melsungen Ag
Baxter International Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neuromodulation and Neurostimulation Pain Management Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neuromodulation and Neurostimulation Pain Management Devices, with revenue, gross margin, and global market share of Neuromodulation and Neurostimulation Pain Management Devices from 2020 to 2025.
Chapter 3, the Neuromodulation and Neurostimulation Pain Management Devices competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Neuromodulation and Neurostimulation Pain Management Devices market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neuromodulation and Neurostimulation Pain Management Devices.
Chapter 13, to describe Neuromodulation and Neurostimulation Pain Management Devices research findings and conclusion.
Table of Contents
92 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
